Purpose of Review The study aims to review the prevention efforts for vaccine preventable diseases. Recent Findings Significant progress in global vaccination coverage has been made since World Health Organization established the Expanded Programme on Immunization to ensure that all children have access to routinely recommended vaccines. Global coverage with vaccines to prevent tetanus, poliomyelitis, or measles has increased from < 5 to ≥ 85% in multiple countries, and for the first time, in 2016, global estimated measles deaths were fewer than 100,000. However, vaccination rates for the third dose of polio vaccine, diphtheria, tetanus toxoids, and pertussis-containing vaccine and first dose of measles-containing vaccine have remained unchanged at 84–86% since 2010, demonstrating a need for new strategies to improve immunization rates especially in low-income regions. Summary In addition to political commitment from governments, disease surveillance efforts should be strengthened. In devel- oped countries, vaccine refusal should be continuously addressed. In this review, tetanus, measles, rubella, and polio vaccinations are discussed with their unique success stories and challenges. . . . . Keywords Measles elimination Tetanus elimination Rubella Polio Vaccine preventable diseases Introduction Development Goal was adopted in 2000 and set a target to reduce the child mortality by
Current Tropical Medicine Reports – Springer Journals
Published: Jun 4, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera